SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601485-21-000025
Filing Date
2021-05-19
Accepted
2021-05-19 17:10:44
Documents
1
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162145860149330.html 4  
1 FORM 4 wf-form4_162145860149330.xml 4 3495
  Complete submission text file 0001601485-21-000025.txt   4829
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Neylan John F. (Reporting) CIK: 0001640447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 21941160